MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Central olfactory structure atrophy is linked to synucleinopathy conversion in idiopathic REM sleep behavior disorder

KA. Woo, JY. Lee, H. Kim, YK. Kim (Seoul, Republic of Korea)

Meeting: 2022 International Congress

Abstract Number: 895

Keywords: Rapid eye movement(REM), Synucleinopathies

Category: Restless Legs Syndrome and Other Sleep Disorders

Objective: We hypothesized that early structural changes in the brain olfactory relevant structures may help early identification of those at risk of future disease conversion to synucleinopathy in patients with iRBD.

Background: The olfactory structures represent one of the earliest sites of a-synuclein pathology in the brain. In the Braak staging system, Lewy pathology is first observed in the olfactory bulb and the dorsal motor nucleus of vagus, followed by amygdala and pons before the nigral dopaminergic neurons are affected. Alternative hypotheses also suggest that Lewy pathology may start intracranial in the olfactory entry route or the amygdala and spread within the brain.

Method: We recruited patients with iRBD and performed baseline assessments for prodromal parkinsonian symptoms, olfactory function, and cognition, along with structural, dopaminergic, and functional imaging. The patients were prospectively followed up for development of overt parkinsonism, and subgroups of patients underwent repeated structural and functional MRI after 4 years.

Results: Twenty patients out of the 51 iRBD patients developed overt synucleinopathy over a mean follow-up period of 4.11 years. At baseline, the iRBD patients had significant atrophy in the olfactory cortex, gyrus rectus, and amygdala, which correlated with severity of depression, urinary problem, and constipation. Amygdala FP-CIT uptake was reduced in the iRBD patients with hyposmia compared to those with normosmia and controls. Brain MRI followed up after 4 years in 22 iRBD patients showed progression of olfactory cortex, gyrus rectus, and amygdala atrophy, with the progression of amygdala atrophy more pronounced in patients with baseline olfactory dysfunction and synucleinopathy converters. Resting-state fMRI in 25 iRBD patients showed that the gyrus rectus-seeded global functional connectivity correlated with mild parkinsonian signs in iRBD. In Cox regression analysis adjusting for age and sex, olfactory cortex, gyrus rectus, and amygdala atrophy significantly predicted disease conversion, respectively.

Conclusion: Our findings demonstrate that alterations in the brain olfactory-related structures, namely the olfactory cortex, gyrus rectus, and amygdala, are closely related to early nonmotor features in the prodromal stages of synucleinopathy, and may be potential indicators of impending overt synucleinopathy.

To cite this abstract in AMA style:

KA. Woo, JY. Lee, H. Kim, YK. Kim. Central olfactory structure atrophy is linked to synucleinopathy conversion in idiopathic REM sleep behavior disorder [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/central-olfactory-structure-atrophy-is-linked-to-synucleinopathy-conversion-in-idiopathic-rem-sleep-behavior-disorder/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/central-olfactory-structure-atrophy-is-linked-to-synucleinopathy-conversion-in-idiopathic-rem-sleep-behavior-disorder/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley